Professor Matthias Koepp

Professional statement

Professor Matthias Koepp is a distinguished consultant neurologist based at the National Hospital for Neurology, Queen Square, London, with a further base in Hemel Hempstead, renowned for his expertise in the fields of epilepsy, epilepsy surgery, consciousness disorders, amnesia, learning disabilities, and cognitive impairment.
 
Professor Koepp graduated with a Doctor of Medicine degree from Freie Universität Berlin in 1993. Upon graduation, he moved to London to advance his training in neurology at the Institute of Neurology and in psychiatry at Imperial College London. He undertook a PhD at University College London, focusing on functional imaging of epilepsies. He has been practising as consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London for nearly 25 year, was promoted to Professor of Neurology at the UCL Queen Square Institute of Neurology in 2009.
 
Professor Koepp's extensive body of academic work consists of over 250 peer-reviewed articles, with his research interests focused on imaging the causes and consequences of epilepsy using fMRI and PET, as well as exploring mechanisms underlying drug-resistant epilepsy and innovative antiepileptic treatment strategies. Both his academic and clinical work focus on better understanding and treating epilepsy as well as its co-morbidities, including mood disorders/depression, cognitive problems/dementia, and associated learning disabilities/autism.  
 
He has been the principal investigator in several anti-epileptic drug trials, including the first anti-epileptogenesis trial in post-stroke epilepsy. He has received recognition for his exceptional contributions to the field of medicine, being the recipient of numerous awards, including the Michael-Prize in 2001, the ILAE Ambassador for Epilepsy Award in 2019, and most recently the prestigious Clinical Science Recognition Award 2023 of the American Epilepsy Society.

He has played a pivotal role as the clinical lead of the MRI-Unit at The Epilepsy Society and has been the principal investigator for several anti-epileptic drug trials, including the first anti-epileptogenesis trial in post-stroke epilepsy.
 
An esteemed member of professional organisations such as the Association of British Neurologists (ABN) and the International League Against Epilepsy (ILAE), Professor Koepp's career is a testament to his commitment to advancing the field of neurology and improving the lives of patients through his expertise, research, and dedication to medical science.